A
Aarti Pharma Labs
AARTIPHARM Share Price
Healthcare650.85
as on 13 Mar 2026 at 15:57
Market Cap
₹5,900 Cr
PE Ratio
28.90
ROCE
17.23%
AARTIPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
5,900
PE Ratio
28.90
PB Ratio
3.01
Dividend Yield
0.73%
ROE
13.69%
ROCE
17.23%
Book Value (₹)
225.71
Face Value (₹)
5.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 44.66% | 44.29% | 43.72% | 42.88% | 43.10% |
| Domestic Institutional Investors (DII) | 10.36% | 7.53% | 7.80% | 6.96% | 7.66% |
| Foreign Institutional Investors (FII) | 8.64% | 7.36% | 7.35% | 8.02% | 7.68% |
| Public Investors | 30.39% | 34.10% | 34.43% | 35.39% | 34.85% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
AARTIPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
543748
NSE Scrip Name
AARTIPHARM
ISIN
INE0LRU01027



